Signaturefd, LLC Tricida, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$8.51 - $13.6 $42 - $68	-5 Reduced 3.76%	128 $1,000
Q2 2022 Aug 10, 2022	BUY	$7.31 - $11.85 $972 - $1,576	133 New	133 $1,000
Q2 2021 Jul 26, 2021	SELL	$3.95 - $5.41 $529 - $724	-134 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$4.37 - $9.46 $135 - $293	31 Added 30.1%	134 $1,000
Q3 2020 Nov 03, 2020	BUY	$8.56 - $26.93 $881 - $2,773	103 New	103 $1,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.